These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. No evidence of significant silencing of Fanconi genes FANCF and FANCB or Nijmegen breakage syndrome gene NBS1 by DNA hyper-methylation in sporadic childhood leukaemia. Meyer S; White DJ; Will AM; Eden T; Sim A; Brown R; Strathdee G Br J Haematol; 2006 Jul; 134(1):61-3. PubMed ID: 16803569 [TBL] [Abstract][Full Text] [Related]
4. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia. Hess CJ; Ameziane N; Schuurhuis GJ; Errami A; Denkers F; Kaspers GJ; Cloos J; Joenje H; Reinhardt D; Ossenkoppele GJ; Zwaan CM; Waisfisz Q Cell Oncol; 2008; 30(4):299-306. PubMed ID: 18607065 [TBL] [Abstract][Full Text] [Related]
5. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. de Winter JP; van der Weel L; de Groot J; Stone S; Waisfisz Q; Arwert F; Scheper RJ; Kruyt FA; Hoatlin ME; Joenje H Hum Mol Genet; 2000 Nov; 9(18):2665-74. PubMed ID: 11063725 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Narayan G; Arias-Pulido H; Nandula SV; Basso K; Sugirtharaj DD; Vargas H; Mansukhani M; Villella J; Meyer L; Schneider A; Gissmann L; Dürst M; Pothuri B; Murty VV Cancer Res; 2004 May; 64(9):2994-7. PubMed ID: 15126331 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation of FANCF plays an important role in the occurrence of ovarian cancer through disrupting Fanconi anemia-BRCA pathway. Wang Z; Li M; Lu S; Zhang Y; Wang H Cancer Biol Ther; 2006 Mar; 5(3):256-60. PubMed ID: 16418574 [TBL] [Abstract][Full Text] [Related]
8. Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia. Tischkowitz MD; Morgan NV; Grimwade D; Eddy C; Ball S; Vorechovsky I; Langabeer S; Stöger R; Hodgson SV; Mathew CG Leukemia; 2004 Mar; 18(3):420-5. PubMed ID: 14749703 [TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469>C-T) with implications to develop acute myeloid leukemia. Behera CK; Gyandeep G; Mishra R; Mohanty RP; Pal A; Behera J; Samal S; Das B Mol Biol Rep; 2023 Jan; 50(1):931-936. PubMed ID: 36369330 [TBL] [Abstract][Full Text] [Related]
10. Constitutional sequence variation in the Fanconi anaemia group C (FANCC) gene in childhood acute myeloid leukaemia. Barber LM; McGrath HE; Meyer S; Will AM; Birch JM; Eden OB; Taylor GM Br J Haematol; 2003 Apr; 121(1):57-62. PubMed ID: 12670332 [TBL] [Abstract][Full Text] [Related]
11. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM. de Winter JP; Rooimans MA; van Der Weel L; van Berkel CG; Alon N; Bosnoyan-Collins L; de Groot J; Zhi Y; Waisfisz Q; Pronk JC; Arwert F; Mathew CG; Scheper RJ; Hoatlin ME; Buchwald M; Joenje H Nat Genet; 2000 Jan; 24(1):15-6. PubMed ID: 10615118 [No Abstract] [Full Text] [Related]
12. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Medhurst AL; Huber PA; Waisfisz Q; de Winter JP; Mathew CG Hum Mol Genet; 2001 Feb; 10(4):423-9. PubMed ID: 11157805 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic variability in patients with Fanconi anemia and biallelic FANCF mutations. Tryon R; Zierhut H; MacMillan ML; Wagner JE Am J Med Genet A; 2017 Jan; 173(1):260-263. PubMed ID: 27714961 [TBL] [Abstract][Full Text] [Related]
14. Gene silencing of FANCF potentiates the sensitivity to mitoxantrone through activation of JNK and p38 signal pathways in breast cancer cells. Li Y; Zhao L; Sun H; Yu J; Li N; Liang J; Wang Y; He M; Bai X; Yu Z; Zheng Z; Mi X; Wang E; Wei M PLoS One; 2012; 7(8):e44254. PubMed ID: 22952942 [TBL] [Abstract][Full Text] [Related]
15. Spectrum and significance of variants and mutations in the Fanconi anaemia group G gene in children with sporadic acute myeloid leukaemia. Meyer S; Barber LM; White DJ; Will AM; Birch JM; Kohler JA; Ersfeld K; Blom E; Joenje H; Eden TO; Malcolm Taylor G Br J Haematol; 2006 May; 133(3):284-92. PubMed ID: 16643430 [TBL] [Abstract][Full Text] [Related]
16. The Fanconi Anemia/BRCA signaling pathway: disruption in cisplatin-sensitive ovarian cancers. D'Andrea AD Cell Cycle; 2003; 2(4):290-2. PubMed ID: 12851475 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants. Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097 [TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in FANCG, FANCF and BRIP1 from head and neck squamous cell carcinoma of the oral cavity. Türke C; Horn S; Petto C; Labudde D; Lauer G; Wittenburg G Int J Oncol; 2017 Jun; 50(6):2207-2220. PubMed ID: 28440438 [TBL] [Abstract][Full Text] [Related]
19. The interferon consensus sequence binding protein (ICSBP/IRF8) activates transcription of the FANCF gene during myeloid differentiation. Saberwal G; Horvath E; Hu L; Zhu C; Hjort E; Eklund EA J Biol Chem; 2009 Nov; 284(48):33242-54. PubMed ID: 19801548 [TBL] [Abstract][Full Text] [Related]
20. FANCF methylation contributes to chemoselectivity in ovarian cancer. Olopade OI; Wei M Cancer Cell; 2003 May; 3(5):417-20. PubMed ID: 12781358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]